Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cilia and flagella associated protein 92 (CFAP92) is a protein encoded by the human CFAP92 gene, also known as KIAA1257, that is involved in the structure and stability of cilia and flagella in eukaryotic cells[5][7]. It localizes to the inner junction of the axoneme, which is a key substructure within cilia and flagella composed of microtubule doublets. While not a traditional therapeutic target (such as a receptor or enzyme), CFAP92's function is essential for the maintenance and proper function of both motile and non-motile cilia, impacting sensory signaling, development, and structural integrity in various tissues. Mutations in CFAP92 have been implicated in rare ciliopathies, including forms of inherited retinal dystrophy[5][7]. There are no known drugs or targeted therapies for CFAP92, and data on clinical biomarkers or safety concerns specific to its modulation are lacking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia and flagella associated protein 92 (CFAP92).